Author:
Li Chang-Yi,Zhou Qing,Yang Ling-Chao,Chen Yi-He,Hou Jian-Wen,Guo Kai,Wang Yue-Peng,Li Yi-Gang
Funder
National Natural Science Foundation of China
Shanghai Committee of Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology
Reference39 articles.
1. Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM, Richardson JA, Hill JA, Olson EN (2002) Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci 99:907–912. doi: 10.1073/pnas.231619298
2. Biesemann N, Mendler L, Kostin S, Wietelmann A, Borchardt T, Braun T (2015) Myostatin induces interstitial fibrosis in the heart via TAK1 and p38. Cell Tissue Res. doi: 10.1007/s00441-015-2139-2
3. Bisserier M, Berthouze-Duquesnes M, Breckler M, Tortosa F, Fazal L, de Regibus A, Laurent AC, Varin A, Lucas A, Branchereau M, Marck P, Schickel JN, Delomenie C, Cazorla O, Soulas-Sprauel P, Crozatier B, Morel E, Heymes C, Lezoualc’h F (2015) Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling. Circulation 131:390–400. doi: 10.1161/CIRCULATIONAHA.114.010686 (discussion 400)
4. Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD (2003) Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J Clin Invest 111:1475–1486. doi: 10.1172/JCI17295
5. Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30–41. doi: 10.1038/nrcardio.2010.165
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献